| CAS NO: | 1169956-08-4 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 生物活性 | Ocaratuzumab (AME 133v) is an Fc-engineered humanizedIgG1anti-CD20monoclonal antibody, with aKdof ~100 pM. Ocaratuzumab exhibits more effective antibody-dependent cell-mediated cytotoxicity (ADCC)[1][2]. |
| IC50& Target | Kd: ~100 pM (CD20)[1] |
| 体外研究 (In Vitro) | AME-133v (0.027-20 μg/mL) 浓度依赖性地抑制了 SKW6.4 细胞中生物素化利妥昔单抗与 CD20 的结合[1]。 |
| CAS 号 | 1169956-08-4 |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com